#200 | 5 Exporting Growth Lessons Most MedTech Founders Learn Too Late For Clinicians)

if you only remember one thing from this episode, remember this: scaling internationally isn't about moving faster, it's about building the operational discipline to survive growth without your business breaking underneath you Welcome to Clinician to CEO, the podcast helping clinicians simplify your go to market strategy so that you can stop guessing and turn your working prototypes into international MedTech businesses. i'm your host, Hakeem Aade. Let's get started. The three things that you're gonna discover in this episode are, number one, why most founders misunderstand what real scaling actually looks like and why comfort will kill your growth.

Number two how AI becomes commercially valuable only when it's wrapped in expertise, workflows, and market access. Number three, why entering international markets without operational infrastructure can become a compliance and leadership nightmare And this episode is based on my five key takeaways and five action points that I took out my conversation with Joshua Gould in episode one nine eight. So I'm gonna try and give you five key takeaways from that conversation in roughly five minutes.

So here goes., Takeaway number one was stop building a business to look successful. And we discussed that many founders start paying themselves like they've already won before they've actually started creating a sustainable business. And the businesses that scale actually reinvest in their business rather than paying themselves, they solve real problems, and they play the long game.

So the action here is review where every pound of profit is going and ask yourself, "Is this helping me build a business or just helping me look successful?" Takeaway number two is operational problems are usually people problems. So we talked about the fact that scaling isn't primarily a systems challenge. It's actually about having the right people, the right culture, and the courage to make difficult decisions when something isn't working.

So the action point here is identify one person, a process, or client relationship that is slowing growth in your business at the moment and decide what action you need to take that you've actually been avoiding. Then takeaway number three, AI is not the product. There's lots of people who are coming out with solutions and are talking about AI, but that's not the real- product. Because anyone can access AI, but very few people know how to apply it effectively.

That's where the real gold is there. The competitive advantage come from expertise, workflows, and implementation, not just the AI itself. The action point here is for you to go and list three tasks that you're currently using AI for, or you think AI is gonna give you a competitive advantage for. Then ask what business problem is this actually solving, for you or for your client.

And if you can't answer that question, then you're probably just using AI because it's fashionable, not because it's solving a real problem. And then takeaway number four, international expansion isn't just sales. Every new market brings compliance requirements, tax implications, legal obligations, and operational complexity. And growth without good infrastructure creates serious risk.

So the action point here is pick one market that you're already considering. Write down the top three regulatory, legal, or operational challenges that you'd need to solve before entering And then use that to decide whether you can do that. And if you can, then carry on with the plans. If you don't feel that you can solve those, then make sure you solve those first before you think about going into that market.

And then takeaway number five, own your backyard first. Because often founders will chase distant opportunities, exciting markets, but they ignore the growth opportunities sitting right in front of them. So before you look elsewhere, make sure you maximize what's already working in your own home market or the markets that are very close to home. And the action point here is ask yourself, have you genuinely exhausted the opportunity in your strongest market that you're already in, which more often than not is your home market?

If the answer is no, don't go anywhere. Focus there first. So my closing thoughts from that conversation was that Joshua's biggest message wasn't about I-AI, it wasn't about international expansion, and it wasn't about scaling. It was about discipline, actually.

It was about the fact that businesses that succeed aren't usually the ones that are moving the fastest. They're the ones actually making the right decisions constantly. So it's all about decision-making if you really go to the crux of it. And it's making those right decisions consistently year after year, while everyone else is looking for shortcuts and excitement.

And as Joshua put it, "Success comes from doing the hard yards." So this week, don't ask, "How do you grow faster?" Ask, "What's the one disciplined decision that you've been avoiding that you need to grasp?" Then go and make it And if you're building a MedTech business and you're not sure whether your next move should be around evidence, market access, commercialization, distributor strategy.

Or adoption. Do not guess. Book a healthcare export accelerator diagnostic Call with me. Use my link in the show notes.

And in that session I'll help you identify the specific constraints blocking your momentum and the commercial move most likely to unlock your progress. Thanks for tuning in. Until next time, thanks for listening. Keep challenging your assumptions and keep growing.